Short answer
BRCA1 and BRCA2 testing looks for inherited variants linked to higher risks of breast, ovarian, prostate, pancreatic, and other cancers. Broad hereditary cancer panels test many genes at once. Panels can find useful non-BRCA answers, but they also increase the chance of uncertain findings, unexpected results, and counseling complexity.
Focused versus broad testing
| Approach | Best fit | Important caveat |
|---|---|---|
| Known familial variant test | When a specific pathogenic variant is already known in the family. | May miss other unrelated hereditary risks. |
| BRCA1/BRCA2 test | When history strongly suggests hereditary breast and ovarian cancer syndrome. | Negative results do not explain every hereditary cancer pattern. |
| Broad cancer panel | Mixed family history, multiple cancers, early-onset cancer, or unclear syndrome. | More variants of uncertain significance may appear. |
| Direct-to-consumer screen | May report selected variants. | Usually not comprehensive clinical hereditary cancer testing. |
When a broader panel adds value
A broader panel can add value when the cancer pattern is mixed, multiple relatives are affected, a younger age of diagnosis suggests more than one gene could fit, or the family history does not point cleanly to BRCA1 or BRCA2 alone. Panels are most helpful when they are paired with counseling before and after testing.
What a VUS means
A variant of uncertain significance is not the same as a pathogenic result. It usually should not be used by itself to change surgery, screening, or family testing decisions while it remains uncertain.
When family history needs context
When the cancer pattern is mixed or unclear, the family history usually matters more than the label on the panel. Testing an affected relative first, confirming the exact genes on the panel, and pairing the result with counseling often answer the question better than choosing the broadest test available.
Questions to ask
- Does my personal or family history meet criteria for clinical genetic counseling or testing?
- Would testing an affected relative first provide a clearer answer?
- What happens if the result is positive, negative, or a variant of uncertain significance?
- Does this test cover sequencing, deletion/duplication analysis, and the genes relevant to my family history?
FAQ
Is BRCA testing enough if the family history is strong?
Sometimes, but not always. A genetic counselor can decide whether BRCA-only testing or a broader panel is more appropriate.
When does a broader panel help?
Broad panels can help when the cancer pattern is mixed, early-onset, or not explained by BRCA alone.
Why can broad panels be harder to interpret?
They can increase the chance of variants of uncertain significance and unexpected findings that need counseling.
Does a negative panel rule out hereditary cancer risk?
No. A negative result does not erase family history, and the wrong gene set can miss the cause.
Should an affected relative be tested first?
Often yes, because testing someone with cancer can give a clearer answer for the family.
What if I get a VUS?
A variant of uncertain significance is usually not used to change management on its own; the result may be reclassified later.
Related guides: hereditary cancer genetic testing, genetic counseling, FDA-authorized genetic tests, and direct-to-consumer genetic testing.